Laurus Bio
- Company typePrivate
- Founded2005
- HeadquartersBengaluru, India
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Laurus Bio firmographics
Firmographics- Name
- Laurus Bio
- Legal name
- Laurus Bio Private Limited
- Website
- https://laurus.bio
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Laurus Bio industry classification
Industry- Product category
- Recombinant Proteins & Biomanufacturing
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO) (AFANAKAF)
Keywords
Where Laurus Bio is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Laurus Bio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain
Revenue model
- Recombinant Protein and Growth Factor Product Sales: Sale of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements including Rc Trypsin, Rc Human Albumin, Rc Transferrin, Rc FGFb, Rc EGF-L, Rc IGF1-LR3, Rc Thermolysin, and Rc Carboxypeptidase B. Products are available in liquid and powder forms for biopharma, cell culture, and food applications.
- CDMO (Contract Development and Manufacturing Organization) Services: Fee-for-service precision fermentation expertise offered as a CDMO to biomanufacturers. Services span clone development, strain engineering, bioprocess and analytical test development, fermentation scale-up, and large-scale commercial manufacturing.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Laurus Bio product offering
Product offeringCore offering
Laurus Bio manufactures animal-origin-free (AOF) recombinant proteins, growth factors, and cell culture media supplements using precision fermentation technology. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from clone development and process optimization through commercial-scale cGMP-compliant biomanufacturing.
Product overview
Laurus Bio is an integrated research-driven biomanufacturing organization offering a portfolio of 100% animal-origin-free (AOF) recombinant proteins and growth factors manufactured through precision fermentation technology. The core product portfolio consists of Rc Trypsin (standard and USP grade), Rc Human Albumin (10% and 20%), Rc Transferrin, Rc Carboxypeptidase B, Rc Thermolysin, Rc FGFb, Rc EGF-L, and Rc IGF1-LR3. These products serve diverse applications including cultured meat, cell culture media, biologics and insulin manufacturing, vaccines, and stem cell culture and regenerative medicine. The company also provides CDMO (Contract Development and Manufacturing Organization) services for precision fermentation, encompassing clone development, strain engineering, bioprocess development, and scale-up capabilities ranging from R&D bench-scale to commercial-scale production (up to 45,000L fermenters). Additionally, Laurus Bio offers customized cell culture media formulations and bio-analytics services. All products are manufactured using expression systems including Escherichia Coli, Pichia Pastoris, and Hansenula polymorpha.
Differentiator
Problem solved
Functional benefit
Products and services
- Rc Carboxypeptidase B
- Rc Human Albumin 20%
- Rc USP Trypsin
- Rc Trypsin (Standard)
- Rc Transferrin
- Rc Thermolysin
- Rc Human Albumin 10%
- Rc FGFb (basic Fibroblast Growth Factor)
- Rc EGF-L (Epidermal Growth Factor - Long)
- Rc IGF1-LR3
- CDMO Services
Quantifiable outcome
- 20 billion doses of medicines made safe with animal-free products
- +2 more outcomes
Companies that use Laurus Bio
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Laurus Bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Laurus Bio partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Laurus LabscoreLaurus Bio is a wholly-owned subsidiary of Laurus Labs, a listed pharmaceutical company. Laurus Labs provides corporate governance, strategic direction, and operational support. Laurus Bio's corporate goals are aligned with those of Laurus Labs. The subsidiary model allows Laurus Bio to leverage Laurus Labs' pharmaceutical industry expertise and resources.
- National Biomedical Resources Indigenization Consortium (NBRIC)minorLaurus Bio (formerly Richcore Life Sciences) is a member of NBRIC, a consortium focused on indigenous development of biomedical resources in India. Through this membership, Laurus Bio participates in national initiatives to build self-sufficiency in biotech manufacturing, including the expansion of recombinant protein manufacturing capabilities.
- Unreasonable GroupminorLaurus Bio (formerly Richcore Life Sciences) was recognized as an Unreasonable Company by the Unreasonable Group, a community of entrepreneurs addressing global challenges. This recognition highlights the company's mission to create safer, more reliable, and more sustainable solutions to tackle current health problems through animal-origin-free biomanufacturing.
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
Laurus Bio competitors and assessment
Company assessmentDirect peers
- Geltor: Animal-free recombinant protein company producing proteins via precision fermentation for food, beauty, and nutrition markets. Direct competitor in animal-origin-free recombinant protein space serving similar end markets.
- Bota Bio: Precision fermentation CDMO offering end-to-end microbial manufacturing services from strain engineering to commercial production. Directly comparable to Laurus Bio's CDMO offering for novel proteins and bio-based products.
- Culture Biosciences: Microbial fermentation CDMO with bioreactor scale-up capabilities and bioprocess development services. Operates a similar business model to Laurus Bio's CDMO services for synthetic biology and fermentation-based manufacturers.
- Perfect Day: Animal-free dairy protein producer using precision fermentation, competing in the same AOF recombinant protein market as Laurus Bio. Both companies serve food industry customers seeking sustainable alternatives to animal-derived ingredients.
Broad incumbents
- Bio-Techne: Major supplier of recombinant proteins and cell culture reagents (R&D Systems brand) for biopharma and academic customers. Direct competitor in recombinant growth factors and cell culture media supplements.
- ADM: Global food ingredient and agricultural processor with growing fermentation and alternative protein capabilities. Competes in the alternative protein space with fermentation-based ingredients, similar to Laurus Bio's cultivated meat serving strategy.
- Codexis: Engineered enzyme and protein manufacturer using directed evolution and protein engineering. Operates in pharmaceutical, food, and industrial markets with overlapping recombinant protein capabilities.
- DSM-Firmenich: Major ingredient and biopharma supplier with fermentation-based manufacturing capabilities across nutrition, health, and personal care. Serves similar end markets to Laurus Bio but at much larger scale with diversified portfolio.
- Novonesis: Large global enzyme and microbial fermentation company (formerly Novozymes) with extensive CDMO capabilities and precision fermentation infrastructure. Operates across food, beverage, and biopharma with broader portfolio than Laurus Bio.
Emerging players
- Ginkgo Bioworks: Synthetic biology platform company providing cell engineering and fermentation services to customers across food, pharma, and industrial biotechnology. Comparable CDMO-like service offerings for novel protein customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Laurus Bio social profiles
Digital presenceLaurus Bio compliance and trust
Trust signalCompliance5 records
Laurus Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Laurus Bio leadership team
Management profileNumber of profiles
Profiles9 records
Laurus Bio funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Laurus Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Laurus Bio
What does Laurus Bio do?
Laurus Bio manufactures animal-origin-free (AOF) recombinant proteins, growth factors, and cell culture media supplements using precision fermentation technology. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from clone development and process optimization through commercial-scale cGMP-compliant biomanufacturing.
Is Laurus Bio a public or private company?
Laurus Bio is a private company. It is classified as corporate owned and is currently operating.
When was Laurus Bio founded?
Laurus Bio was founded in 2005. It employs 251 to 500 people.
Where is Laurus Bio based?
Laurus Bio is headquartered in Bengaluru, India, in the Asia region.
How does Laurus Bio make money?
Two revenue lines are on record. Recombinant Protein and Growth Factor Product Sales are the primary driver. The others are CDMO (Contract Development and Manufacturing Organization) Services.
Who are Laurus Bio's main competitors?
Direct peers on record are Geltor, Bota Bio, Culture Biosciences and Perfect Day. Broad incumbents are Bio-Techne, ADM, Codexis, DSM-Firmenich and Novonesis. Ginkgo Bioworks is listed as an emerging player.
Does Laurus Bio have an API?
No public API is recorded for Laurus Bio.
What industry is Laurus Bio in?
Laurus Bio's product category is Recombinant Proteins & Biomanufacturing. Its primary akta.pro industry code is AFANAKAF, Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO). Its SIC code is 2836.